Curaleaf Holdings (CURLF) Non-Current Deferred Tax Liability (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Non-Current Deferred Tax Liability of $212.0 million for Q4 2025, down 13.39% year-on-year from $244.8 million in Q4 2024, and down 13.39% on a QoQ basis from $244.8 million in Q4 2024.

Curaleaf Holdings (CURLF) Non-Current Deferred Tax Liability (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Non-Current Deferred Tax Liability for 7 consecutive years, with $212.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 13.39% year-over-year to $212.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $212.0 million (down 13.39% YoY) and the FY2025 annual result came in at $212.0 million, down 13.39% from the prior year.
  • Non-Current Deferred Tax Liability retreated to $212.0 million in Q4 2025 per CURLF's latest filing, from $244.8 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for CURLF reached as high as $342.6 billion in Q1 2022 and fell as low as $212.0 million in Q4 2025.
  • A 5-year average of $23.1 billion and a median of $303.5 million in 2021 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability jumped 153837.26% — and 2024, when it declined 17.64%.
  • Year by year, Non-Current Deferred Tax Liability stood at $257.8 million in 2021, then rose by 19.86% to $309.0 million in 2022, then fell by 3.82% to $297.2 million in 2023, then slipped by 17.64% to $244.8 million in 2024, then decreased by 13.39% to $212.0 million in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $212.0 million, $244.8 million, and $276.2 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 212.00 Mn
Dec 31, 2025 212.00 Mn
Dec 31, 2024 244.77 Mn
Dec 31, 2024 244.77 Mn
Sep 30, 2024 276.22 Mn
Sep 30, 2024 276.22 Mn
Jun 30, 2024 285.59 Mn
Jun 30, 2024 285.59 Mn
Dec 31, 2023 297.19 Mn
Dec 31, 2023 297.19 Mn
Sep 30, 2023 311.04 Mn
Sep 30, 2023 311.04 Mn
Jun 30, 2023 318.21 Mn
Jun 30, 2023 318.21 Mn
Dec 31, 2022 308.97 Mn
Dec 31, 2022 308.97 Mn
Sep 30, 2022 332.31 Mn
Sep 30, 2022 332.31 Mn
Jun 30, 2022 334.81 Mn
Jun 30, 2022 334.81 Mn